Skip to main content
 This program is not active.
Not Found
Digital Seminar

Decoding Psychopharmacology: A Prescription for Improved Clinical Practice



Your Complete Guide to the Uses and Side Effects of Psychoactive Medications

Psychoactive medications are an indispensable part of treating many mental health problems. Patients are often prescribed several medications from different physicians. Do you feel like you should know more about how these medications work and why they are prescribed? Knowledge about the major psychoactive drug classes will help you answer clients’ questions with greater confidence, accuracy, and effectiveness, thereby improving your delivery of patient services.

This recording gives you the tools needed to more effectively communicate with your patients and prescribers about how these medications work, their benefits, and the side effects and dangerous reactions associated with them. Learn from an expert, N. Bradley Keele, PhD, who has over 20 years of psychopharmacology research experience and teaches clinical neuroscience and psychopharmacology at Baylor University.


Details

Product Details
Average Rating:
Not yet rated
Faculty:
N. Bradley Keele, PhD
Duration:
5 Hours 55 Minutes
Format:
Audio and Video
Copyright:
Oct 12, 2017
Product Code:
POS020680
Media Type:
Digital Seminar
Access:
Never expires.

CPD


Continuing Professional Development Certificates
- PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This online program is worth 6.0 hours CPD.

Handouts

Faculty

N. Bradley Keele, PhD's Profile

N. Bradley Keele, PhD Related seminars and products

Baylor University


N. Bradley (Brad) Keele, Ph.D., is Associate Chair of the Department of Psychology & Neuroscience at Baylor University. He has more than 20 years of experience teaching psychopharmacology to both graduate and undergraduate students. Prior to coming to Baylor in 1998, he was a post-doctoral fellow at the National Institutes of Health in Bethesda, MD.

Brad is an expert on the neurobiology of complex emotional behaviors such as fear and anxiety disorders and depression. His research lab, with support from the NIH, examines pharmacological and physiological mechanisms involved in emotional behavior and psychopathology. He has published over 25 peer-reviewed, primary research papers, and book chapters, and has made presentations at several dozen national scientific meetings. Brad earned his B.S. degree in psychology from Baylor, and his Ph.D. in neuroscience from the University of Texas Medical Branch in Galveston.

Brad is a dynamic and energetic speaker who weaves together empirical findings with everyday examples. His audience (especially his students) appreciates his natural ability to present psychopharmacology in a friendly and practical manner. Brad is passionate about providing behavioral health care providers with practical information that is easy to understand, improving the lives of people living with mental health problems.


Speaker Disclosures:
Financial: Dr. N. Bradley Keele has an employment relationship with Baylor University. He receives a speaking honorarium and recording royalties from PESI, Inc. Dr. Keele has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. N. Bradley Keele is a member of the Society for Neuroscience, the American Association for the Advancement of Science, and the Association for Psychological Science.


Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Objectives

  1. Articulate the clinical uses of the five major psychotropic medication classes- antidepressants, mood stabilizers, anti-anxiety agents, antipsychotics and psychostimulants.
  2. Describe the common side effects of antidepressants, mood stabilizers, anti-anxiety agents, antipsychotics and psychostimulants.
  3. Communicate the potential benefits and risks of using psychotropic medication to treat a wide array of conditions.
  4. Explore psychotropic medication treatment options for clients with Attention Deficit/Hyperactivity Disorder.
  5. Analyze the actions, therapeutic uses, and side effects of antidepressants in adults and children. Implement effective methods for collaborating with clients, families and prescribers in order to build a comprehensive treatment plan.
  6. Explore specific ethical issues and their resolve to the everyday practice of clinical psychopharmacology.

Outline

THE “NUTS AND BOLTS” OF PSYCHOPHARMACOLOGY

  • Pharmacokinetics
  • Pharmacodynamics
  • Preclinical and clinical trials
  • FDA approved and off-label use

HOW THE NERVOUS SYSTEM WORKS

  • Neurons: building blocks of brain and behavior
  • Neurotransmission: transmitters and receptors

SEDATIVE-HYPNOTICS, ANXIOLYTIC, AND ANTICONVULSANT MEDICATIONS

  • Benzodiazepines and barbiturates
  • Anticonvulsants
  • New research findings in behavioral methods that permanently extinguish fear

ANTIDEPRESSANT MEDICATIONS

  • Tricyclics and SSRIs
  • SNRIs and new generation Antidepressants 
  • Depression is not a “chemical imbalance”: The neurogenic hypothesis
  • New research on the short-term Antidepressant effect of ketamine (aka “Special K”)

CASE STUDIES

  • When should Antidepressants be continued indefinitely?
  • Can quality of life improve in treatment-resistant OCD?

ANTIMANIC MEDICATIONS

  • Lithium carbonate
  • Anticonvulsants as mood stabilizers
  • Should Bipolar illness be classified as a thought disorder?

ANTIPSYCHOTIC MEDICATIONS

  • Neuroleptics
  • Atypical antipsychotics
  • Everything we think we know about schizophrenia is wrong

ANALGESIC MEDICATIONS

  • The physiology and pharmacology of pain
  • Non-opiate treatment of pain
  • Opiates and the crisis of dependence

ETHICS AND SPECIAL POPULATIONS

  • Drugs and society
  • Is the DSM-5® hindering the hunt for new medications?
  • Should children and adolescents be prescribed antidepressants?
  • Elderly clients

CASE STUDIES

  • Schizophrenia, Bipolar, or Schizoaffective?  Does treatment depend on diagnosis?
  • Childhood depression

Target Audience

  • Addiction Counselors
  • Case Managers
  • Counselors
  • Educators
  • Marriage & Family Therapy
  • Nurse Practitioner
  • Nurses
  • Psychiatric Nurse Practitioners
  • Psychiatrists
  • Psychologists
  • Social Workers

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or email info@pesi.com.au.

Please wait ...

Back to Top